¿Cómo se comparó el EPS reciente de ZIVO con las expectativas?
¿Cómo fue el desempeño de los ingresos de Zivo Bioscience Inc ZIVO en el último trimestre?
¿Cuál es la estimación de ingresos para Zivo Bioscience Inc?
¿Cuál es la puntuación de calidad de ganancias de Zivo Bioscience Inc?
¿Cuándo informa Zivo Bioscience Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Zivo Bioscience Inc?
¿Superó Zivo Bioscience Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$9.75
Precio de apertura
$9.4
Rango del día
$9.4 - $9.75
Rango de 52 semanas
$6.95 - $22
Volumen
1
Volumen promedio
1.1K
EPS (TTM)
-2.67
Rendimiento de dividendos
--
Cap. de mercado
$37.9M
¿Qué es ZIVO?
Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. The company is headquartered in Troy, Michigan and currently employs 7 full-time employees. The company went IPO on 2000-10-06. The firm operates in the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production and cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its product candidates are at different stages of development for different applications. The company is developing a product candidate targeting poultry gut health and Avian Influenza, Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Algal biomass for human consumption, and Biomass for supporting skin health/anti-aging. The company is focused on licensing and selling natural bioactive ingredients derived from the proprietary algae cultures to animal, human and dietary supplement, and medical food manufacturers. The company sells its vegan protein powder, which is a dried green algae nutritional product, under the brand name ZIVOLife.